SUPPORTS RECOVERY AND BODY COMPOSITION In a clinical trial, participants aged 55 to 71 saw lean body mass increases over 16 weeks with concurrent fat reduction
Status Not FDA-approved as of July 30, 2026
Semaglutide Safety Semaglutide has accumulated years of post-marketing safety data across millions of patients a depth of real-world evidence that no research peptide can approach
For instance, GLP-1 receptor agonist peptides such as semaglutide mimic a naturally occurring gut hormone to enhance satiety, reduce energy intake and lower blood glucose, resulting in significant weight loss in adults with obesity or type 2 diabetes, even when paired with lifestyle interventions
If you have concerns about alcohol consumption and its effects on your health or treatment, please discuss these with your healthcare provider during your consultation
Riboflavin deficiency occurs commonly in low- and middle-income countries